期刊文献+

血管内皮生长因子及受体在急性白血病中的表达及临床意义 被引量:1

Clinical significance of vascular endothelial growth factor and its receptors in acute leukemia
下载PDF
导出
摘要 目的 探讨血管生成在急性白血病(AL)发病、预后中的作用。方法 应用免疫组化法检测30例初治AL患者诱导化疗前后骨髓中微血管密度(MVD)、血管内皮生长因子(VEGF)及受体KDR、Flt-1变化与临床特征的关系。结果 初治AL患者骨髓组织中KDR、VEGF和MVD的表达高于对照组(P<0.05);完全缓解(CR)后MVD及VEGF阳性率明显下降;未完全缓解(NR)组的MVD及VEGF阳性率与治疗前无显著性下降(P>0.05);Kaplan-Meier分析显示治疗前VEGF阴性组的生存时间大于VEGF阳性组(P<0.05)。结论 AL骨髓中存在血管生成,VEGF与AL的发病及预后有关。
出处 《江苏医药》 CAS CSCD 北大核心 2003年第4期277-279,共3页 Jiangsu Medical Journal
  • 相关文献

参考文献7

  • 1汤大侃,张国平,金惠铭.用计算机图象分析方法定量测定毛细血管数的一种新方法[J].中国微循环,2002,6(2):115-116. 被引量:3
  • 2[2]Perez-Atayde AR,Sallan SE,Tedrow U,et al.Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.Am J Pathol,1997,150:815-821.
  • 3[3]Pruneri G,Bertolini F,Soligo D,et al.Angiogenesis in myelodysplastic syndromes.Br J Cancer,1999,81:1398-1401.
  • 4[4]Padro T,Ruiz S,Bieker R,et al.Increased angiogenesis in bone marrowofpatients with acute myeloid leukemia.Blood,2000,95:2637-2644.
  • 5[5]Aguayo A,Kantarjian H,Manshouri T,et al.Angiogenesis in acute and chronic leukemia and myelodysplastic syndromes.Blood,2000,96:2240-2245.
  • 6[6]Bellamy WT,Richter L,Sirjani D,et al.Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.Blood,2001,97:1427-1434.
  • 7[7]Padro T,Bieker R,Ruiz S,et al.Overexpression of vascular endothelial cell growth factor(VEGF) and its cellular receptor KDR(VEGFR-2)in the bone marrow of patients with acute myeloid leukemia.Leukemia,2002,16:1302-1311.

二级参考文献2

共引文献2

同被引文献17

  • 1Koistinen P, Slltonen T, Mantymaa P, et al. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitricoxide synthase under the control of a vascular endothelial growth factor signaling system[J]. Leukemia,2001, 15(9): 1433~1441.
  • 2Bellamy WT, Richer T, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [J]. Cancer Res, 1999, 59(3):728.
  • 3Fiedler W, Graeven U, Erguns, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myloid leukemia[J]. Blood, 1997, 89 (6):1870~1875.
  • 4Aguayo A, Estey E, Kantarjian H, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J].Blood, 1999,94(11):3717~3721.
  • 5Kini AR, Peterson LA, Tallman MS et al. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retincic acid [J] Blood 2001, 97(12):3919~3924.
  • 6De Bont ES, Rosali S, Jacobs S, et al. Increased bone marrow vascularization in patient with acute myeloid leukemia, a possible role for vascular endothelial growthfactor[J]. Br J Haematol 2001,113(2):296~304.
  • 7Petez-Atayde AR, Sallan SE, et al. spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia [J]. AmJ Pathol, 1997,150(3):815~821.
  • 8Aguayo A,Kantarjian H,Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].Blood,2000,96(6):2240-2245.
  • 9Kini AR, Kay NE,Peterson LC. Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia [J].Leukemia,2000,14(8):1414~1418.
  • 10Aguayo A, O'Brien S,Keating M,et al. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia[J].Blood,2000,96(2):768~770.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部